Opendata, web and dolomites

PhaseControl SIGNED

How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PhaseControl project word cloud

Explore the words cloud of the PhaseControl project. It provides you a very rough idea of what is the project "PhaseControl" about.

innovative    chemoprevention    cohort    model    ripk3    fundamental    solid    alcoholic    definition    molecular    newly    human    form    cancer    white    serves    hepatocytes    chronic    transition    patients    metabolic    prevention    systematic    organ    cells    inflammation    mediate    ground    cell    breaking    disease    stable    indicating    networks    murine    risk    nash    apoptosis    relevance    liver    interact    myeloid    modulate    carcinoma    exploring    stage    prediction    drivers    made    phases    decompensation    undergoes    independent    regulation    unexpected    programmed    critical    death    steatohepatitis    warning    examine    necroptosis    healthy    inflammatory    reactivity    hcc    progression    driver    hepatocellular    hepatocarcinogenesis    road    phasecontrol    functions    diseases    signs    wat    discovered    dependent    molecules    tissue    regulate    functionally    genetic    transitions    explore    mlkl    demonstrating    initially    alterations    regulatory    mediators    adipose    mutations   

Project "PhaseControl" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM AACHEN 

Organization address
address: Pauwelsstrasse 30
city: AACHEN
postcode: 52074
website: www.ukaachen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙997˙840 €
 EC max contribution 1˙997˙840 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-COG
 Funding Scheme ERC-COG
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM AACHEN DE (AACHEN) coordinator 1˙997˙840.00

Map

 Project objective

The progression from a healthy liver towards non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) serves as a model for chronic diseases in a solid organ, demonstrating how an initially stable stage undergoes critical transitions along several defined phases. Defining the molecular drivers of these phase transitions will open the road for the definition of warning signs, risk prediction approaches and prevention of disease decompensation in human liver disease. We recently made several ground-breaking findings indicating that the molecules RIPK3 and MLKL – which regulate a novel form of programmed cell death called necroptosis – are crucial mediators of these phase transitions, but they might have unexpected and cell-death-independent functions. Therefore, PhaseControl aims at exploring the specific functions of these molecules at the critical phase transitions towards NASH/HCC. Specifically, I propose to apply a systematic approach and innovative methods to

1) explore cell-type specific RIPK3- and MLKL-dependent regulatory networks in white adipose tissue (WAT), hepatocytes and myeloid cells in murine NASH development and define cell-death independent functions of MLKL in metabolic regulation; 2) explore how inflammatory pathways in hepatocytes modulate the reactivity and specific responses towards necroptosis at the transition towards hepatocellular carcinoma (HCC); 3) examine apoptosis- and necroptosis-specific genetic alterations and driver mutations that mediate the transition from chronic inflammation to HCC; 4) evaluate in a cohort of human patients if these newly discovered pathways can be used for risk-prediction approaches and might be chemoprevention targets against HCC.

The expected results will establish a novel concept how programmed cell death, inflammation and metabolic pathways functionally interact in hepatocarcinogenesis with fundamental relevance for risk prediction and chemoprevention of human liver cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PHASECONTROL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PHASECONTROL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

KineTic (2020)

New Reagents for Quantifying the Routing and Kinetics of T-cell Activation

Read More  

NEUTRAMENTH (2018)

A redox-neutral process for the cost-efficient and environmentally friendly production of Menthol

Read More  

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More